Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Respiratory drug delivery

Byron, P.R. (Ed.) Respiratory Drug Delivery, CRC Press, Boca Raton, FL., 1990. [Pg.140]

CG Thiel. From Susie s question to CFC free an inventor s perspective on forty years of MDI development and regulation. Phoenix, Arizona Respiratory Drug Delivery, Y, 1996, pp. 115-123. [Pg.500]

G Hochhaus, S Suarez, RJ Gonzalez-Rothi, H Schreier. Pulmonary Targeting of Inhaled Glucocorticoids How Is It Influenced by Formulation Respiratory Drug Delivery VI, Hilton Head, SC, 1998, pp. 45-52. [Pg.500]

AR Clark. Metered Atomisation for Respiratory Drug Delivery. PhD thesis, Loughborough University of Technology, UK, 1991. [Pg.501]

Poochikian, G. and Bertha, C.M., Regulatory view on current issues pertaining to inhalation drug products, Respiratory Drug Delivery VIII Conference, Vol. 1, 2000, pp. 159-164 [www.rddonline.com]. [Pg.50]

Moren, F., In vitro and in vivo Performance of Powder Inhalers, Proc. Respiratory Drug Delivery II, Interpharm Press, Buffalo Grove, IL, 1990. [Pg.114]

Schultz, R.K., Miller, N.C., Smith, D.K., and Ross, D.L.,J. Biopharm. Sci., 3 115-122 (1992). Hill, M., Characteristics of an Active Multiple Dose Dry Powder Inhaler, Proc. Respiratory Drug Delivery IV, Interpharm Press, Buffalo Grove, IL, 1994, pp. 109-116. [Pg.115]

Johnson, M., Fluticasone Propionate Pharmaeokinetic and Pharmaeodynamie Implieations of Different Aerosol Delivery Systems. Proc. Respiratory Drug Delivery VI, Interpharm Press, Buffalo grove, IL, 1998, pp. 61-70. [Pg.115]

Reiners M, Stang N, Wob-Heuss E, In Respiratory Drug Delivery VII (Eds Dalby RN, Byron PR, Farr SJ, Peart J), pp. 333-336. Serentec Press, Raleigh, 2000. [Pg.86]

York, P. and Hanna, M. (1996). Particle engineering by supercritical fluid technologies for powder inhalation drug delivery. Proc. Conf. Respiratory Drug Delivery V, Phoenix, AZ, 231-239. [Pg.214]

Lucas P, Clarke MJ, Anderson K, Tobyn MJ, Staniforth JN. The role of fine particle excipients in pharmaceutical dry powder aerosols. Paper presented at Respiratory Drug Delivery VI, 1998. [Pg.248]

Howlett D, Colwell J, Goldsmith S, McCallion ON. Correlation of extractables and leach -ables from marketed pMDIs. Paper presented at Respiratory Drug Delivery VIII, 2002. [Pg.250]

Smyth HDC, Garmise RJ, Cooney DJ, Zimmerer RO, Pipkin JD, Hickey AJ. Influence of physical form of Captisol particles on performance as a dry powder aerosol carrier. Paper presented at Respiratory Drug Delivery IX, Palm Desert, California, 2004. [Pg.250]

Clark, A. R., Dasovich, N., Gonda, I., and Chan, H. K. The balance between biochemical and physical stability for inhalation protein powders rhDNAse as an example, in Proceedings of Respiratory Drug Delivery V. Buffalo Grove, IL Interpharm Press, 1996. [Pg.266]

Gerrity, T. R. Pathophysiological and disease constraints on aerosol delivery, in Respiratory Drug Delivery. Boca Raton, FL CRC Press, 1990. [Pg.266]

Keller, M., Mueller-Walz, R., Gilchrist, P., et al. Effects of storage on the in vitro performance of formoterol powder blends in the SkyePharma DPI, in Proceedings of Respiratory Drug Delivery VII. Raleigh, NC Serentec Press, 2000. [Pg.267]

Phillips, E. M., and Hill, M. Developing a powder inhalation system for insulin delivery Lessons learned, in Proceedings of Respiratory Drug Delivery VIII. Raleigh NC Davis Horwood International Publishing, 2002. [Pg.268]

York, P, Hanna, M., Shekunow, Y., and Humphreys, G. 0. Microfine particle formation by SEDS (solution enhanced dispersion by supercritical fluids) Scale up by design, in Proceedings of Respiratory Drug Delivery VI. Buffalo Grove, IL Interpharm Press, 1998. [Pg.269]

G. Hochhaus, S. Suarez, R. J. Gonzales-Rothi, and H. Schreier, Pulmonary targeting of inhaled glucocorticoids How is it influenced by formulation , Respiratory Drug Delivery VI(R. Dalby, P. Byron, and S. J. Farr, eds.), Interpharm Press, 1998, p. 45. [Pg.84]

Hickey, A. J. (ed.) (1996) Inhalation Aerosols Physical and Biological Basis for Therapy. Marcel Dekker, New York. Byron, P.R. (ed.) (1990) Respiratory Drug Delivery. CRC Press, Boca Raton, FL. [Pg.272]

Niven, R. W. (2002), Powders and processing Deagglomerating a dose of patents and publications, in Dalby, R. N., Byron, P.R., Peart, J., and Farr, S. J., Eds., Respiratory Drug Delivery VIII, Davis Horwood International Publishing, Raleigh, NC, pp 257-266. [Pg.713]


See other pages where Respiratory drug delivery is mentioned: [Pg.139]    [Pg.139]    [Pg.140]    [Pg.140]    [Pg.136]    [Pg.136]    [Pg.268]    [Pg.86]    [Pg.87]    [Pg.266]    [Pg.268]    [Pg.718]    [Pg.718]   
See also in sourсe #XX -- [ Pg.901 ]




SEARCH



Respiratory drug delivery changes

Respiratory drug delivery insulin inhalation

Respiratory drugs

© 2024 chempedia.info